Assessing operative risk and benefit in elderly patients with heart valve disease

Authors:
Open Access
Publisher website
Google Scholar
Abstract
The prevalence of heart valve disease increases with age, with the predominance of degenerative aetiology, as shown by the Euro Heart Survey on valvular heart disease.1 Advanced age is one of the pre-eminent risk factors of mortality and major morbidity after cardiac surgery. Nevertheless, several reports (including randomized studies) showed that consistent benefits can be achieved from cardiac surgery and percutaneous valve therapies in elderly patients,2–5 in terms of quality-of-life improvement, alleviation of symptoms, prevention of major adverse events, and increased survival. The clinical decision-making and individual risk profile evaluation in this context have been so far particularly challenging, leading to the clinical question of utility vs. futility. Concomitantly, the economic burden in high-risk elderly patients could have crucial implications and should be considered before proceeding, due to reduced expectancy of life. Moreover, ethical implications should be taken into account. The therapeutic decision in this context should be reached through a shared decision-making process, not only by a multidisciplinary ‘heart team’ discussion, but also by informing the patient thoroughly, and finally by deciding with the patient and family which treatment option is optimal, taking into account the patient perspective.6

This publication has 14 references indexed in Scilit: